000

ILSUNG PHARM

No trades
See on Supercharts
Market capitalization
‪232.28 B‬KRW
−3220KRW
‪−20.94 B‬KRW
‪78.05 B‬KRW
‪742.84 K‬
Beta (1Y)
1.00

About ILSUNG PHARM

Headquarters
Seoul
Employees (FY)
236
Founded
1954
ISIN
KR7003120003
FIGI
BBG000BDMS39
ILSUNG IS Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products. Its products include contrast media, patches, antibiotics, antiviral agents, dermatologic agents, cardiovascular agents, antidiabetic agents, analgesics, muscle relaxants, neuropsychiatric agents, antitussives, and expectorants. The company was founded by Yoon Byung-Kang in 1954 and is headquartered in Seoul, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 003120 is 18810 KRW — it has decreased by 1.42% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange ILSUNG PHARM stocks are traded under the ticker 003120.
003120 stock is 5.46% volatile and has beta coefficient of 1.00. Check out the list of the most volatile stocks — is ILSUNG PHARM there?
Yes, you can track ILSUNG PHARM financials in yearly and quarterly reports right on TradingView.
003120 stock has fallen by 10.21% compared to the previous week, the month change is a 18.04% fall, over the last year ILSUNG PHARM has showed a 30.20% decrease.
003120 net income for the last quarter is ‪−39.70 B‬ KRW, while the quarter before that showed ‪4.48 B‬ KRW of net income which accounts for −985.95% change. Track more ILSUNG PHARM financial stats to get the full picture.
Today ILSUNG PHARM has the market capitalization of ‪130.04 B‬, it has decreased by 0.95% over the last week.
Yes, 003120 dividends are paid annually. The last dividend per share was ‪1.50 K‬ KRW. As of today, Dividend Yield (TTM)% is 7.86%. Tracking ILSUNG PHARM dividends might help you take more informed decisions.
Like other stocks, 003120 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ILSUNG PHARM stock right from TradingView charts — choose your broker and connect to your account.
003120 reached its all-time high on Mar 3, 2023 with the price of 38000 KRW, and its all-time low was 2620 KRW and was reached on May 18, 2004.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 236.00 employees. See our rating of the largest employees — is ILSUNG PHARM on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ILSUNG PHARM technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ILSUNG PHARM stock shows the sell signal. See more of ILSUNG PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ILSUNG PHARM EBITDA is ‪−4.92 B‬ KRW, and current EBITDA margin is −6.29%. See more stats in ILSUNG PHARM financial statements.